I Still Like the Stock, but This Definitely Isn't Warren Buffett's Berkshire Hathaway Anymore

Berkshire Hathaway’s Q1 portfolio changes under new CEO Greg Abel point to a smaller, more selective equity book: 16 positions were sold entirely, several of them each under 1% of portfolio value, while the company added or expanded stakes in Alphabet, Delta Air Lines, and Macy’s. The article also highlights exits from losing positions such as UnitedHealth, Constellation Brands, and Domino’s Pizza, suggesting a greater willingness to cut underperformers and pursue special situations. Berkshire’s cash pile hit a record $397 billion, reinforcing the possibility of a shift toward fewer stock picks and more outright ownership of businesses like OxyChem.

Analysis

The market is likely over-indexing on the symbolic shift in Berkshire’s quarter and underpricing the portfolio-construction signal: capital is being redeployed from low-conviction “watchlist” equities into a smaller set of higher-expected-value situations. That is bearish for the stock-picking ecosystem around Berkshire itself, but bullish for the handful of names that can absorb meaningful capital without moving the thesis. The second-order effect is a tighter filter on what qualifies as investable: balance-sheet strength, asset backing, and visible catalyst paths matter more than brand-name quality alone.

The biggest loser is not necessarily the companies sold; it is the category of “good businesses with no actionable catalyst.” That group includes airlines, regulated healthcare, and mature consumer franchises where price can look cheap for months while fundamentals drift lower. In contrast, hard-asset optionality and restructuring value now have a better chance of earning a seat at the table, which should widen the dispersion between asset-rich turnarounds and asset-light compounders with no immediate catalyst.

The contrarian read is that this is less about abandoning public equities and more about acknowledging that public markets are not offering enough spread for a large buyer. If that’s right, the cash pile becomes a signal of discipline rather than fear, and the real upside is from wait-time optionality: Berkshire can step in when volatility creates 20-30% dislocations over a 1-3 month window. The key risk is that management gets more active in “special situations” exactly when cycle risk is peaking, which can turn bargain hunting into value traps if macro slows or sector-specific secular erosion accelerates.

For the broader tape, this favors asset-backed, catalyst-rich names over premium-duration franchises. It is mildly negative for defensive quality at any price, and mildly positive for event-driven setups where control of assets or balance sheet repair can re-rate the equity within 6-18 months. The market should also expect lower correlation between Berkshire’s actions and the implied ranking of “best stocks,” which reduces the informational value of the 13F as a signal.

Key Decisions for Investors

• Long M vs. short a basket of structurally challenged consumer/transport names such as DAL and DPZ for 3-6 months: Macy’s has explicit asset monetization optionality, while the shorts face higher certainty of margin compression; target 1.5-2.0x downside capture on the short leg if growth stays soft.
• Buy out-of-the-money 6-12 month calls on GS against a financed put spread on UNH: the former benefits from any revival in corporate/event-driven activity and capital deployment, while the latter remains exposed to multi-quarter remediation risk; asymmetric if the market rotates toward financial optionality and away from healthcare overhangs.
• Enter a long OXY / short CVX pair trade for 6-9 months: Berkshire’s willingness to add to asset-heavy energy exposure while trimming a larger integrated exposure supports the view that smaller, more levered cash-flow sensitivity can outperform if crude stays range-bound; risk is a broad oil selloff below marginal incentive levels.
• Avoid chasing BRK.B at a premium to NAV after this quarter; instead, wait for a volatility spike or equity drawdown that could lift the implied discount-to-look-through value and create a better entry. The near-term upside is likely lower than the headline cash balance suggests, but the downside is also buffered, so use it as a defensive allocator only on weakness.
• Speculative long M on any post-earnings pullback, but size it as an event-driven trade, not a long-term compounder. The setup is a 6-18 month catalyst path with rerating potential if asset sales or real estate monetization become credible; exit quickly if management signals no meaningful balance-sheet actions.